학술논문

Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors
Document Type
Article
Source
In: European Journal of Cancer. (European Journal of Cancer, May 2024, 203)
Subject
Language
English
ISSN
18790852
09598049